Zymeworks has seen its share price move sharply in recent years, and with fresh licensing money coming in from big pharma, the question now is how well that market value lines up with what its balance...
Source LinkZymeworks has seen its share price move sharply in recent years, and with fresh licensing money coming in from big pharma, the question now is how well that market value lines up with what its balance...
Source Link
Comments